Involvement of Cytochrome C Release and Caspase Activation in Toosendanin-induced PC12 Cell Apoptosis
Overview
Authors
Affiliations
Our previous study showed that toosendanin, a triterpenoid derivative isolated from a Chinese traditional medicine, could induce apoptosis in PC12 cells. In this study we confirmed the apoptosis-inducing effect of toosendanin in PC12 cells with new evidences in morphology and biochemistry: the shrinkage of cytosol, the condensation and fragmentation of nuclei and the formation of DNA ladder. It was also demonstrated that toosendanin decreased the PC12 cell viability in a time- and concentration-dependent manner. To elucidate the pathway linked with the toosendanin-induced apoptosis, the cytochrome c in the cytosol and the cleavage of poly(ADP-ribose) polymerase (PARP) were examined. The obtained results showed that toosendanin caused the release of cytochrome c from mitochondria into the cytosol and then led to the activation of caspase, indicating that the cytochrome c release and caspase activation were involved in the toosendanin-induced apoptosis process. These results suggested the possibility that toosendanin could serve as a candidate for anti-cancer drug.
Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3.
Wu Y, Chen L, Feng C, Wang T, He S, Zheng D BMC Oral Health. 2023; 23(1):846.
PMID: 37946196 PMC: 10634166. DOI: 10.1186/s12903-023-03602-x.
Citrus Essential Oils in Aromatherapy: Therapeutic Effects and Mechanisms.
Agarwal P, Sebghatollahi Z, Kamal M, Dhyani A, Shrivastava A, Singh K Antioxidants (Basel). 2022; 11(12).
PMID: 36552586 PMC: 9774566. DOI: 10.3390/antiox11122374.
Design, synthesis, and insecticidal activity evaluation of piperine derivatives.
Zhang C, Tian Q, Li Y Front Chem. 2022; 10:973630.
PMID: 35958231 PMC: 9360595. DOI: 10.3389/fchem.2022.973630.
Fan W, Fan L, Wang Z, Yang L Front Pharmacol. 2022; 12:795565.
PMID: 35140606 PMC: 8819599. DOI: 10.3389/fphar.2021.795565.
Natural products: a hope for glioblastoma patients.
Vengoji R, Macha M, Batra S, Shonka N Oncotarget. 2018; 9(31):22194-22219.
PMID: 29774132 PMC: 5955138. DOI: 10.18632/oncotarget.25175.